Stocks
GlaxoSmithKline (GSK) P/E US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | 32.2 | 14.4 | 28.7 | 30.9 | 30.5 | 43.4 | ||
| Changes by years, y/y, % | +60% | -55% | +100% | +8% | -1% | +8.0% | |||
GlaxoSmithKline. P/E
GlaxoSmithKline. P/E, changes, %
GlaxoSmithKline (GSK) P/E US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| P/E | ? | 27.0 | 24.3 | 31.0 | 30.5 | 38.9 | 43.4 | |
| Changes by years, y/y, % | +44% | +124% | +15% | +13% | +24% | |||
| Changes by quarters, q/q, % | +61% | -10% | +27% | -1% | +28% | |||
